MORSE events and selected market-access events from around the world.
Find a MORSE programme or a selected industry event.
Join a MORSE programme or meet our team where market-access conversations are happening.
Next MORSE-hosted event
One-day interactive training on Canadian public payer negotiations, reimbursement strategy and a simulated negotiation.
For: Pharmaceutical professionals in market access, commercial, medical affairs and related teams.
Take away: Apply payer-negotiation strategy through expert discussion, real cases and a simulation.
MORSE-hosted events and appearances, updated as the calendar changes. Other industry events stay on this page.
Opens your calendar app when supported.
Use this link in your calendar’s subscribe-by-URL option:
Select and copy the URL.
Google Calendar (desktop): Other calendars → From URL. Outlook: Add calendar → Subscribe from web.
Relevant market-access, reimbursement and HTA events, selected for their value to the field.
November 2026
By ISPOR
Why it matters: Health economics and outcomes research with direct evidence-to-decision relevance. Optional preconference short courses on 8 November require separate registration.
By Canadian Organization for Rare Disorders (CORD)
Why it matters: A focused Canadian rare-disease policy and access audience.
By MATRIX Healthcare Strategists
Why it matters: Canadian patient-support programme forum covering reimbursement, private drug coverage, payer complexity and the path to patients.
By Canadian Association for Healthcare Reimbursement (CAHR)
Why it matters: Canadian pricing, reimbursement and patient-access policy with public and private market-access stakeholders.
December 2026
By Benefits Canada
Why it matters: Canadian private drug-plan management and payer decisions, with plan sponsors and pharmaceutical stakeholders.
By European Commission
Why it matters: Medicines legislation, evidence and policy changes affecting market entry and patient access.
February 2027
By Canadian Association for Healthcare Reimbursement (CAHR)
Why it matters: Western Canadian reimbursement and life-sciences policy forum. Save the date; the 2027 programme is not yet published.
By ACCESS Forum
Why it matters: Dedicated market-access forum covering HEOR, payer engagement, rare disease and patient advocacy.
March 2027
By Terrapinn
Why it matters: Dedicated pharmaceutical evidence, pricing, reimbursement and market-access programme.
By The Canadian Institute
Why it matters: Direct Canadian market-access, drug-pricing and reimbursement programme involving payers, patients and industry.
No external events are currently approved for this list.
Event details may change. Check the organizer’s page for the latest information.
